Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Debt Rating Affirmed, Outlook Raised

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fitch Ratings has affirmed its ratings on Agilent Technologies' debt and has revised its outlook to 'positive' from 'stable.'

The Chicago-based rating agency affirmed Agilent's Issuer Default Rating of 'BBB,' as well as a 'BBB' rating on the firm's senior unsecured revolving credit facility and its senior unsecured notes.

Fitch said that it raised its outlook on Agilent due to "greater confidence in Agilent's operating and financial profile. The company's increasing percentage of organic sales from the faster growing and more profitable Life Sciences and Chemical Analysis segments should drive higher and less uneven operating performance over time," Fitch said in a statement.

The agency also cited Agilent's recently completed $1.5 billion acquisition of Varian as a catalyst for greater revenues in its Life Sciences and Chemical Analysis segments.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.